What is Sulphamethoxazole and Trimethoprim tablets used for?

In the pharmaceutical industry, the combination of Sulfamethoxazole and Trimethoprim (SMZ-TMP)—also known as Co-trimoxazole—is a classic example of synergistic antimicrobial therapy. As a pharmacist, I view this as a powerful “sequential blockade” tool, where the two components work together to inhibit bacterial folic acid synthesis far more effectively than either could alone.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): Often a first-line treatment for uncomplicated UTIs, pyelonephritis, and prostatitis caused by susceptible strains of E. coli or Klebsiella.

  • Respiratory Infections: Used for acute exacerbations of chronic bronchitis and certain types of pneumonia.

  • Pneumocystis Jirovecii Pneumonia (PJP): The “gold standard” for both the treatment and prophylaxis of PJP in immunocompromised patients (such as those with HIV/AIDS).

  • Gastrointestinal Infections: Effective against Shigellosis, Traveler’s Diarrhea, and Cholera.

  • MRSA Skin Infections: Increasingly utilized for community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections.

Mechanism of Action: The Sequential Blockade

SMZ-TMP is bactericidal because it inhibits two consecutive steps in the biosynthesis of nucleic acids and proteins essential to many bacteria:

Sulfamethoxazole: A sulfonamide that competitively inhibits the enzyme dihydropteroate synthase. It mimics PABA (para-aminobenzoic acid), preventing the bacteria from synthesizing dihydrofolic acid.

Trimethoprim: It binds to and reversibly inhibits the next enzyme in the chain, dihydrofolate reductase, preventing the reduction of dihydrofolic acid to tetrahydrofolic acid (the active form of folate).

By attacking two points in the same metabolic pathway, the combination significantly reduces the development of bacterial resistance and enhances the overall potency.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, SMZ-TMP (Standard 400 mg/80 mg or DS 800 mg/160 mg) is a high-volume essential:

  • Fixed-Dose Ratio (5:1): As a WHO-GMP manufacturer, we strictly maintain the 5:1 ratio of Sulfamethoxazole to Trimethoprim. This ratio is optimized to achieve a steady-state plasma concentration ratio of 20:1, which is the peak synergistic level in the blood.

  • Solubility & Dissolution: Sulfamethoxazole is poorly soluble in water. We utilize specific granulation and disintegration agents to ensure the tablet meets pharmacopeial dissolution standards (BP/USP/IP), ensuring maximum bioavailability.

  • Global Tender Staple: Because it is on the WHO Model List of Essential Medicines, it is a constant requirement for government health tenders and B2B distributors in Africa and Southeast Asia.

  • Packaging for Stability: We prioritize PVC/PVDC or Alu-Alu blister packaging to protect the formulation from moisture, ensuring a 36-month shelf life for export to Zone IVb climates.

 

What is Co-Trimoxazole Sulfamethoxazole Trimethoprim used for?

In the pharmaceutical industry, the combination of Sulfamethoxazole and Trimethoprim (SMZ-TMP)—clinically referred to as Co-trimoxazole—is a classic example of synergistic antimicrobial therapy. As a pharmacist, I characterize this as a “sequential blockade” antibiotic, which remains a staple in both community and hospital settings due to its broad-spectrum efficacy and excellent tissue penetration.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): A primary treatment for acute uncomplicated cystitis and pyelonephritis, particularly those caused by E. coli or Klebsiella species.

  • Pneumocystis Jirovecii Pneumonia (PJP): The “gold standard” for both the treatment and prophylaxis of PJP in immunocompromised patients (e.g., those with HIV/AIDS).

  • Respiratory Tract Infections: Used for acute exacerbations of chronic bronchitis and acute otitis media in children.

  • Gastrointestinal Infections: Indicated for Shigellosis and Traveler’s Diarrhea.

  • MRSA Management: Increasingly utilized as a cost-effective oral option for treating community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections.

Mechanism of Action: The Sequential Blockade

The synergy of this combination is achieved by inhibiting two consecutive steps in the bacterial synthesis of Tetrahydrofolic acid (essential for DNA production):

Sulfamethoxazole: Acts as a structural analog of PABA, competitively inhibiting the enzyme dihydropteroate synthase.

Trimethoprim: Reversibly inhibits the enzyme dihydrofolate reductase.

By targeting the same metabolic pathway at two different points, the combination becomes bactericidal, whereas each component used alone is typically only bacteriostatic.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, SMZ-TMP is a high-volume, essential medicine requiring specific technical rigor:

  • Fixed-Dose Ratio (1:5): Whether in standard (80mg/400mg) or Double Strength (160mg/800mg) formats, maintaining the 1:5 ratio is critical to achieving the 1:20 plasma concentration ratio required for peak synergy.

  • API Handling: As a WHO-GMP manufacturer, we manage the slightly acidic nature of Sulfamethoxazole and the basic nature of Trimethoprim during the granulation process to ensure final tablet stability and uniform dissolution.

  • Stability for Export: This is a core product for international B2B distributors and government health tenders. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life in Zone IVb (hot and humid) climates like Africa and Southeast Asia.

  • Regulatory Compliance: Our Mumbai-based facility provides complete CTD/eCTD Dossiers and stability data (BP/USP/IP) to support our partners in global registration.

 

How to use Clotrimazole during pregnancy?

In the pharmaceutical industry, Clotrimazole is a broad-spectrum imidazole antifungal agent. As a pharmacist, I view Clotrimazole as one of the most reliable and clinically preferred treatments for vulvovaginal candidiasis (yeast infections) during pregnancy, as it has a well-established safety profile compared to systemic (oral) antifungals.

Primary Clinical Applications

  • Vulvovaginal Candidiasis: Treatment of vaginal yeast infections, which are more common during pregnancy due to hormonal changes that alter the vaginal $pH$ and glycogen levels.

  • Topical Fungal Infections: Treatment of skin infections like athlete’s foot, ringworm, or intertrigo in pregnant patients.

Guidelines for Use During Pregnancy

While Clotrimazole is generally considered safe, the method of administration is critical for pregnant patients:

Topical and Vaginal Route Preferred: Clinical guidelines (such as those from the FDA and MHRA) generally recommend topical or vaginal Clotrimazole over oral Fluconazole during pregnancy to minimize systemic exposure to the fetus.

Avoid the Applicator: During the second and third trimesters, many obstetricians advise manual insertion of vaginal tablets (pessaries) rather than using the plastic applicator. This is to prevent any accidental trauma to the cervix.

Duration of Therapy: While 1-day or 3-day treatments are common for the general population, pregnant patients are often prescribed a 7-day course of a lower-strength cream or pessary (e.g., 100 mg) to ensure complete eradication of the infection and reduce the risk of recurrence.

Mechanism of Action

Clotrimazole works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane.

  • It inhibits the enzyme 14-$\alpha$ demethylase, which is responsible for converting lanosterol to ergosterol.

  • This leads to increased membrane permeability and the leakage of intracellular phosphorus, ultimately causing the death of the fungal cell (fungicidal action).

Because the drug is applied topically or intravaginally, systemic absorption is negligible (typically <0.5% for vaginal and <0.1% for skin), which is why it is preferred for use during pregnancy.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, Clotrimazole is a high-demand “Essential Medicine” for maternal health:

  • Formulation Variety: As a WHO-GMP manufacturer, we offer Clotrimazole in multiple formats, including 100 mg/200 mg/500 mg vaginal tablets, 1% and 2% vaginal creams, and topical sprays.

  • Stability & $pH$ Balance: For vaginal formulations, we ensure the excipients maintain a $pH$ that is compatible with the vaginal environment (approx. $pH$ 4.5), which is especially important during the physiological changes of pregnancy.

  • Packaging for Global Markets: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to protect the sensitive pessaries from moisture, ensuring a 36-month shelf life for export to Zone IVb regions.

  • Regulatory Dossiers: Our Mumbai hub provides comprehensive CTD/eCTD Dossiers to support international B2B partners in registering these products for maternal health programs.

What is Clopidogrel Aspirin 75 mg used for?

In the pharmaceutical industry, the combination of Clopidogrel (75 mg) and Aspirin (75 mg) is a cornerstone of Dual Antiplatelet Therapy (DAPT). As a pharmacist, I view this fixed-dose combination (FDC) as a strategic clinical tool that provides synergistic protection by inhibiting two distinct pathways of platelet activation.

Primary Clinical Uses

  • Acute Coronary Syndrome (ACS): Indicated for the reduction of atherothrombotic events in patients with unstable angina or those who have recently suffered a myocardial infarction (heart attack).

  • Post-Stent Implantation: A critical requirement after Percutaneous Coronary Intervention (PCI). It prevents stent thrombosis, a life-threatening complication where a clot forms on the newly placed metal or drug-eluting stent.

  • Ischemic Stroke & TIA: Used to prevent secondary occurrences in patients who have experienced a minor ischemic stroke or a Transient Ischemic Attack (TIA).

  • Peripheral Arterial Disease (PAD): Helps manage patients with established PAD to reduce the risk of major adverse cardiovascular events (MACE).

Mechanism of Action: Dual Pathway Inhibition

This FDC targets platelet aggregation from two different angles:

Aspirin (75 mg): Irreversibly inhibits the COX-1 enzyme, which blocks the synthesis of Thromboxane $A_2$ ($TXA_2$), a powerful promoter of platelet aggregation.

Clopidogrel (75 mg): A prodrug that, once metabolized by the liver (primarily via CYP2C19), irreversibly blocks the $P2Y_{12}$ ADP receptor on the platelet surface. This prevents the activation of the GPIIb/IIIa receptor complex, the final common pathway for platelet cross-linking.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this combination is technically demanding due to the chemical characteristics of the APIs:

  • Bilayer Tablet Technology: Aspirin is prone to hydrolysis and can be incompatible with Clopidogrel Bisulphate if mixed in a single-layer matrix. As a WHO-GMP manufacturer, we often utilize bilayer compression to physically separate the two components, ensuring maximum stability.

  • Enteric Coating: To minimize gastric mucosal irritation—a common side effect of Aspirin—we apply an enteric coating to the Aspirin component, ensuring it bypasses the stomach and dissolves in the small intestine.

  • Stability for Global Trade: Clopidogrel is highly hygroscopic. We prioritize Alu-Alu blister packaging to ensure a stable 24-month shelf life, even in Zone IVb (hot and humid) climates like Africa and Southeast Asia.

  • Regulatory Support: Our Mumbai-based hub provides comprehensive CTD/eCTD Dossiers and comparative dissolution studies to assist international B2B partners in rapid product registration.

What is Clopidogrel 75 mg tablet used for?

In the pharmaceutical industry, Clopidogrel Bisulphate 75 mg is the gold-standard P2Y12 platelet inhibitorAs a pharmacist, you recognize this as a critical “anti-aggregant” used to prevent atherothrombotic events. Unlike anticoagulants (like Warfarin), which target clotting factors, Clopidogrel specifically targets the “stickiness” of platelets.

Primary Clinical Uses

  • Recent Myocardial Infarction (Heart Attack): To reduce the rate of a recurrent stroke or heart attack.

  • Acute Coronary Syndrome (ACS): Used in patients with unstable angina or NSTEMI, often in combination with Aspirin (Dual Antiplatelet Therapy – DAPT).

  • Recent Ischemic Stroke: Indicated for patients with a history of recent stroke to prevent further cerebrovascular events.

  • Peripheral Arterial Disease (PAD): Used to reduce the risk of cardiovascular death in patients with established PAD (claudication).

  • Stent Maintenance: Essential post-stenting to prevent “stent thrombosis,” a life-threatening complication where a clot forms on the newly placed hardware.

Mechanism of Action

Clopidogrel is a prodrug that requires hepatic bioactivation via the CYP450 enzyme system (primarily CYP2C19).

It works by irreversibly binding to the P2Y12 adenosine diphosphate (ADP) receptor on the platelet surface. By blocking this receptor, it prevents the activation of the GPIIb/IIIa receptor complex, which is necessary for platelets to bind to fibrinogen and stick to each other. Because the binding is irreversible, the affected platelets are inhibited for the remainder of their lifespan (approx. 7–10 days).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clopidogrel 75 mg is a high-volume essential:

  • Polymorphism Control: Clopidogrel Bisulphate exists in multiple polymorphic forms (Form I and Form II). As a WHO-GMP manufacturer, we strictly control the crystallization process to ensure we use the more stable Form II, which provides consistent bioavailability and shelf-life.

  • Stability & Sensitivity: The API is highly sensitive to moisture and light. We utilize Alu-Alu blister packaging to ensure the product remains stable for 36 months, even in the harsh conditions of Zone IVb export markets (Africa, Southeast Asia).

  • Bioequivalence (BE): This is a competitive market. Our Mumbai-based facility provides comprehensive BE studies and CTD/eCTD Dossiers to prove our generic version is bioequivalent to the innovator (Plavix), facilitating smooth international registration.

  • Drug Interactions: We provide technical data regarding the “CYP2C19” interaction, warning against the co-administration of Proton Pump Inhibitors (PPIs) like Omeprazole, which can reduce Clopidogrel’s efficacy.

What is Clopidogrel 75 mg tablet used for?

In the pharmaceutical industry, Clopidogrel 75 mg is a standard-of-care thienopyridine-class antiplatelet agent. As a pharmacist, I characterize Clopidogrel as a vital “blood thinner” (though technically an anti-aggregant) used to prevent atherothrombotic events in patients with high-risk cardiovascular profiles.

Primary Clinical Uses

  • Acute Coronary Syndrome (ACS): Used to manage patients with unstable angina or NSTEMI (Non-ST elevation myocardial infarction), often in combination with Aspirin (Dual Antiplatelet Therapy or DAPT).

  • Recent Myocardial Infarction (MI): Prescribed to prevent a second heart attack in patients who have recently suffered one.

  • Recent Ischemic Stroke: Used to reduce the risk of a recurrent stroke in patients with a history of ischemic cerebrovascular events.

  • Peripheral Arterial Disease (PAD): Indicated to improve circulation and reduce the risk of vascular complications in patients with established PAD.

  • Post-Stent Implantation: Critical for preventing stent thrombosis after the placement of coronary stents.

Mechanism of Action

Clopidogrel is a prodrug that requires hepatic bioactivation by the cytochrome P450 system (primarily CYP2C19).

Irreversible Inhibition: Once activated, it selectively and irreversibly binds to the P2Y12 subtype of ADP receptors on the surface of platelets.

Prevention of Aggregation: By blocking these receptors, it prevents the activation of the GPIIb/IIIa receptor complex, which is necessary for platelets to bind to fibrinogen and to each other.

Life of the Platelet: Because the binding is irreversible, the affected platelets are inhibited for the remainder of their lifespan (approximately 7–10 days).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clopidogrel 75 mg is a high-volume essential medicine:

  • Polymorphism Control: Clopidogrel Bisulphate exists in different polymorphic forms (Form I and Form II). As a WHO-GMP manufacturer, we strictly control the crystallization process to ensure we use the most stable and bioavailable form.

  • Moisture Sensitivity: Clopidogrel is highly susceptible to hydrolysis. We utilize Alu-Alu blister packaging almost exclusively to ensure a stable 24-month shelf life, especially for export to Zone IVb climates (Africa, Southeast Asia).

  • Bioequivalence: Since this is a life-saving medication, we conduct rigorous comparative dissolution and bioequivalence studies against the innovator (Plavix) to ensure therapeutic equivalence.

  • Global B2B Supply: Clopidogrel is a staple for hospital tenders and chronic care pharmacies. Our Mumbai hub provides complete CTD/eCTD Dossiers to facilitate registration in international markets.

What is Clonidine 150 mg used for?

Technical Correction: Standard tablet dosages for Clonidine are typically 100 mcg (0.1 mg), 150 mcg (0.15 mg), or 200 mcg (0.2 mg). A dose of 150 mg would be 1,000 times the standard therapeutic dose and would be considered a lethal overdose. I will proceed with the technical profile for the 150 mcg (0.15 mg) strength, which is a common international standard.

Primary Clinical Uses

  • Hypertension: Used as a second-line treatment for high blood pressure, particularly in cases of “resistant hypertension” where other agents have failed.

  • ADHD (Attention Deficit Hyperactivity Disorder): Used (often as an extended-release formulation) to treat ADHD in children and adults, frequently as an adjunct to stimulants to manage impulsivity and sleep issues.

  • Withdrawal Management: Extensively utilized to manage the physical symptoms of opioid, alcohol, and nicotine withdrawal (such as tachycardia, sweating, and agitation).

  • Pain Management: Used off-label for chronic pain conditions, including neuropathic pain and migraine prophylaxis.

  • Menopausal Symptoms: Occasionally prescribed to reduce the frequency and severity of hot flashes.

Mechanism of Action

Clonidine acts by stimulating $\alpha_2$-adrenoceptors in the brainstem (specifically the vasomotor center of the medulla).

This stimulation results in a reduction of sympathetic outflow from the central nervous system to the heart, kidneys, and peripheral vasculature. The result is a decrease in peripheral resistance, a decrease in heart rate, and a decrease in blood pressure. It essentially “quiets” the body’s adrenaline-driven stress response at the source.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clonidine is a high-precision, low-dose molecule:

  • Micro-Dose Content Uniformity: Since the active ingredient is in micrograms, as a WHO-GMP manufacturer, we utilize validated trituration and geometric dilution processes. This ensures the minute amount of API is perfectly distributed across the excipient matrix to avoid batch failure.

  • Stability & Shelf Life: While the molecule is relatively stable, we prioritize Alu-Alu blister packaging to protect against moisture and light, ensuring a 36-month shelf life for export to Zone IVb regions.

  • B2B & Niche Demand: While not a “mass-market” drug, it is a high-value niche product for psychiatric and hypertension clinics. Our Mumbai-based facility provides the CTD/eCTD Dossiers required for international registration.

  • Safety Warning (Rebound Hypertension): As a pharmacist, you are aware that abrupt cessation can cause a hypertensive crisis. We ensure our professional labeling and Product Information Leaflets (PIL) carry clear warnings regarding gradual tapering.

What is Clonazepam 2mg used for?

In the pharmaceutical industry, Clonazepam 2 mg is a potent, long-acting benzodiazepine of the nitrobenzodiazepine class. As a pharmacist, you recognize this as a high-strength dosage, typically reserved for the management of severe seizure disorders or acute panic states where a sustained therapeutic effect is required.

Primary Clinical Uses

  • Epilepsy and Seizure Disorders: Indicated as standalone or adjunctive therapy for Lennox-Gastaut syndrome (petit mal variant), akinetic, and myoclonic seizures. It is also used for absence seizures that do not respond to succinimides.

  • Panic Disorder: Used to treat panic attacks, with or without agoraphobia, by significantly reducing the intensity of the “fight or flight” response.

  • Akathisia and Movement Disorders: Often used off-label to manage severe restlessness induced by antipsychotic medications or to treat Restless Legs Syndrome (RLS).

  • Acute Manic Episodes: Occasionally used in clinical settings as an adjunct to mood stabilizers to control the agitation associated with bipolar mania.

Mechanism of Action

Clonazepam acts as a positive allosteric modulator of the $\text{GABA}_A$ receptor. It enhances the binding of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the Central Nervous System (CNS).

When Clonazepam binds to its specific site on the receptor, it increases the frequency of chloride channel opening. This leads to an influx of chloride ions, hyperpolarizing the neuron and making it less likely to fire. This results in the characteristic anticonvulsant, sedative, and anxiolytic effects.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clonazepam 2 mg is a high-precision CNS product:

  • Low-Dose Uniformity: Since the active ingredient is potent even at 2 mg, as a WHO-GMP manufacturer, we utilize validated dry blending or wet granulation to ensure absolute content uniformity, preventing “hot spots” in the batch.

  • Controlled Substance Logistics: Because Clonazepam has a potential for dependence, it is classified under Schedule IV (or similar international narcotic controls). Our Mumbai-based facility manages the strict documentation and licensing requirements needed for legal export.

  • Stability for Global Trade: Clonazepam is sensitive to moisture and light. We prioritize Alu-Alu blister packaging to ensure a stable 36-month shelf life, especially for export to Zone IVb climates (Africa, SE Asia, and Latin America).

  • Dossier Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence studies against the innovator (Rivotril/Klonopin) to facilitate registration in international B2B markets.

What is Clobazam 10mg used for?

In the pharmaceutical industry, Clobazam 10 mg is a unique 1,5-benzodiazepine that stands out from more common 1,4-benzodiazepines (like Diazepam) due to its specialized profile. As a pharmacist, I characterize Clobazam as an essential adjunctive anticonvulsant that offers a favorable balance between seizure control and sedation.

Primary Clinical Uses

  • Lennox-Gastaut Syndrome (LGS): Used as a secondary or adjunctive treatment for seizures associated with this severe form of childhood-onset epilepsy.

  • Refractory Epilepsy: Indicated for patients whose seizures are not adequately controlled by primary anti-epileptic drugs (AEDs).

  • Anxiety Disorders: While its primary use is neurological, it is prescribed for the short-term management of severe anxiety, particularly when a less sedating benzodiazepine is preferred.

  • Catamenial Epilepsy: Sometimes used for the short-term prevention of seizures that occur in a predictable pattern related to the menstrual cycle.

Mechanism of Action

Clobazam acts as a selective agonist at the  receptor. It enhances the inhibitory effect of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter.

By binding to the benzodiazepine site on the GABA receptor, Clobazam increases the frequency of chloride channel opening. This leads to hyperpolarization of the neuron, making it less likely to fire and thereby raising the seizure threshold. Because of its 1,5-substitution, it typically causes fewer psychomotor side effects and less daytime sleepiness than traditional benzodiazepines.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clobazam is a high-precision CNS (Central Nervous System) molecule:

  • Controlled Substance Management: As a WHO-GMP manufacturer, we maintain strict adherence to international narcotics and psychotropic conventions. Exporting Clobazam requires specific import/export permits and rigorous chain-of-custody documentation.

  • Dose Uniformity: Because it is a potent 10 mg tablet, we utilize validated wet granulation and blending protocols to ensure absolute content uniformity, preventing the risk of “seizure breakthrough” or “over-sedation” due to batch variation.

  • Stability for Global Trade: Clobazam is stable, but we prioritize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, Middle East, and Southeast Asia).

  • Regulatory Dossiers: Our Mumbai hub provides comprehensive CTD/eCTD Dossiers and bioequivalence data to support our international B2B partners in registering this specialized AED.

What is Clarithromycin 500mg used for?

In the pharmaceutical industry, Clarithromycin 500 mg is a semi-synthetic macrolide antibiotic derived from Erythromycin. As a pharmacist, I view Clarithromycin as a superior choice over older macrolides due to its improved acid stability, better tissue penetration, and its active metabolite (14-hydroxyclarithromycin) which provides synergistic antimicrobial activity.

Primary Clinical Uses

  • Helicobacter pylori Eradication: A critical component of “Triple Therapy” (usually combined with Amoxicillin and a Proton Pump Inhibitor like Omeprazole) to treat peptic ulcers and prevent recurrence.

  • Lower Respiratory Tract Infections: Highly effective for community-acquired pneumonia (CAP), acute exacerbations of chronic bronchitis, and “atypical” pneumonias caused by Legionella or Mycoplasma.

  • Upper Respiratory Tract Infections: Used for acute maxillary sinusitis, tonsillitis, and pharyngitis, especially in patients allergic to Penicillins.

  • Skin and Soft Tissue Infections: Treatment of uncomplicated infections like cellulitis, folliculitis, and erysipelas.

  • MAC Prophylaxis: Used to prevent or treat disseminated Mycobacterium avium complex (MAC) infections in immunocompromised patients (e.g., those with HIV/AIDS).

Mechanism of Action

Clarithromycin is primarily bacteriostatic. It works by penetrating the bacterial cell wall and binding to the 50S ribosomal subunit.

By binding at this specific site, it inhibits translocation, the process where the growing peptide chain moves along the ribosome. This halts bacterial protein synthesis, effectively preventing the bacteria from growing and multiplying, allowing the host’s immune system to clear the infection.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Clarithromycin 500 mg is a high-value antibiotic requiring specialized expertise:

  • Overcoming Bitterness: The Clarithromycin API is notoriously bitter. As a WHO-GMP manufacturer, we utilize advanced film-coating technology or specialized taste-masking polymers to ensure the 500 mg tablet is palatable for patients.

  • Acid Stability: Unlike Erythromycin, Clarithromycin is stable in gastric acid. However, we still optimize our formulation to ensure consistent dissolution and bioavailability, aiming for bioequivalence with the innovator (Biaxin/Klacid).

  • Stability for Global Trade: Clarithromycin is sensitive to moisture. We prioritize Alu-Alu blister packaging to guarantee a 24–36 month shelf life, particularly for export to Zone IVb climates (Africa, Southeast Asia, and the Middle East).

  • B2B & Registration: Our Mumbai-based hub provides comprehensive CTD/eCTD Dossiers and stability data to support our international partners in registering this essential antibiotic.

Add to cart